Seoul National University Hospital
Seoul, South Korea
NCT Number: NCT03826615
To evaluate the effect of oral gabapentin premedication on hyperalgesia in elderly patients undergoing staged bilateral cataract operations under monitored anesthesia care
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Seoul, South Korea
It has been reported that patients with bilateral cataract complained more pain and discomfort during the second consecutive eye surgery compared to the first eye surgery.
Gabapentin is an anticonvulsant drug, which has been extended the use to perioperative analgesia, and anxiolysis.
Therefore, the investigators conducted this randomized, controlled study to evaluate the effects of gabapentin premedication on patients' subjective sensations, including intraoperative anxiety, perceptions of pain, and light sensitivity, in the second cataract operations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive gabapentin 100mg orally for 3 times a day during the period of first and second cataract operations
Time frame: during the operation
intraoperative pain perception evaluated by VAS in first and second cataract surgery
Seoul National University Hospital
Other
The Effect of Gabapentin Pretreatment on Hyperalgesia in Elderly Patients Undergoing Staged Bilateral Cataract Operations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07625475
Central Nervous System Sensitization, Hyperalgesia
Guelph, Ontario, Canada
View Trial DetailsNCT00825422
Hyperalgesia, Nervous System Diseases
Bordeaux, France
View Trial DetailsNCT04902547
Agnosia, Chronic Pain
Winnipeg, Manitoba, Canada
View Trial DetailsNCT01594047
Hyperalgesia, Nervous System Diseases
Milan, Italy
View Trial Details